Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia

References

• Müller-NordhornJBintingSRollSWillichSNAn update on regional variation in cardiovascular mortality within EuropeEur Heart J200829101316132618256043
   PubMed Web of Science ®Google Scholar
• BorénJWilliamsKJThe central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicityCurr Opin Lipidol201627547348327472409
   PubMed Web of Science ®Google Scholar
• StefanuttiCMorozziCDi GiacomoSNew clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemiaCurr Med Chem201219284861486822963620
   PubMed Web of Science ®Google Scholar
• McClureDLValuckRJGlanzMHokansonJESystematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to presentPharmacoepidemiol Drug Saf200716213214317072896
   PubMed Web of Science ®Google Scholar
• DerosaGLimasCPMacíasPCEstrellaAMaffioliPDietary and nutraceutical approach to type 2 diabetesArch Med Sci201410233634424904670
   PubMed Web of Science ®Google Scholar
• ZhangYLiXZouDTreatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberineJ Clin Endocrinol Metab20089372559256518397984
   PubMed Web of Science ®Google Scholar
• YinJXingHYeJEfficacy of berberine in patients with type 2 diabetes mellitusMetabolism200857571271718442638
   PubMed Web of Science ®Google Scholar
• DongHZhaoYZhaoLLuFThe effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trialsPlanta Med201379643744623512497
   PubMed Web of Science ®Google Scholar
• DongHWangNZhaoLLuFBerberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysisEvid Based Complement Alternat Med2012201259165423118793
   PubMed Web of Science ®Google Scholar
• DerosaGMaffioliPCiceroAFBerberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trialsExpert Opin Biol Ther20121281113112422780092
   PubMed Web of Science ®Google Scholar
• ChenWMiaoYQFanDJBioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in ratsAAPS PharmSciTech201112270571121637946
   PubMed Web of Science ®Google Scholar
• PanGYWangGJLiuXDFawcettJPXieYYThe involvement of P-glycoprotein in berberine absorptionPharmacol Toxicol200291419319712530470
   PubMedGoogle Scholar
• ChaeHWKimIWJinHEKimDDChungSJShimCKEffect of ion-pair formation with bile salts on the in vitro cellular transport of berberineArch Pharm Res200831110311018277615
   PubMed Web of Science ®Google Scholar
• ShanYQRenGWangYXBerberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein effluxMetabolism201362344645623079743
   PubMed Web of Science ®Google Scholar
• ZhouSLimLYChowbayBHerbal modulation of P-glycoproteinDrug Metab Rev20043615710415072439
   PubMed Web of Science ®Google Scholar
• Di PierroFPutignanoPVillanovaNMontesiLMoscatielloSMarchesiniGPreliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetesClin Pharmacol2013516717424277991
   PubMedGoogle Scholar
• DerosaGBonaventuraABianchiLBerberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patientsExpert Opin Biol Ther201313111495150623971720
   PubMed Web of Science ®Google Scholar
• DerosaGBonaventuraABianchiLEffects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patientsJ Biol Regul Homeost Agents201327371772824152839
   PubMed Web of Science ®Google Scholar
• DerosaGRomanoDD’AngeloAMaffioliPBerberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high dosesAtherosclerosis20152391879225577665
   PubMed Web of Science ®Google Scholar
• Di PierroFVillanovaNAgostiniFMarzocchiRSoveriniVMarchesiniGPilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic controlDiabetes Metab Syndr Obes2012521321722924000
   PubMedGoogle Scholar
• Di PierroFBelloneIRapacioliGPutignanoPClinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statinsDiabetes Metab Syndr Obes20158899625678808
   PubMed Web of Science ®Google Scholar
• LiYJiangLJiaZA meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemiaPLoS One201496e9861124897342
   PubMed Web of Science ®Google Scholar
• LiXLiuCDuanZGuoSHMG-CoA reductase inhibitors from Monascus-fermented riceJ Chem20132013872056
   Web of Science ®Google Scholar
• MillánJCiceroAFTorresFAngueraAEffects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: a meta-analysis of randomised controlled trialsClin Investig Arterioscler2016284178187
   Google Scholar
• CameronJRanheimTKulsethMALerenTPBergeKEBerberine decreases PCSK9 expression in HepG2 cellsAtherosclerosis2008201226627318355829
   PubMed Web of Science ®Google Scholar
• World Medical AssociationWorld Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjectsJ Postgrad Med200248320620812432198
   PubMedGoogle Scholar
• Atherosclerosis2016 ESC/EAS Guidelines for the Management of Dyslipidaemias Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.08.018Accessed October 20, 2016
   Google Scholar
• NannoniGAlìADi PierroFDevelopment of a new highly standardized and granulated extract from Monascus purpureus with a high content of monacolin K and KA and free of inactive secondary monacolins and citrininNutrafoods2015144197205
   Google Scholar
• NCEPThird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
   PubMed Web of Science ®Google Scholar
• ChenCYuZLiYFichnaJStorrMEffects of berberine in the gastrointestinal tract – a review of actions and therapeutic implicationsAm J Chin Med20144251053107025183302
   PubMed Web of Science ®Google Scholar
• HuangHNHuaYYBaoGRXieLHThe quantification of monacolin K in some red yeast rice from Fujian province and the comparison of the other productChem Pharm Bull (Tokyo)200654568768916651767
   PubMed Web of Science ®Google Scholar
• GordonRYCoopermanTObermeyerWBeckerDJMarked variability of monacolin levels in commercial red yeast rice products: buyer beware!Arch Intern Med2010170191722172720975018
   PubMed Web of Science ®Google Scholar
• ZhuLYauLFLuJGCytotoxic dehydromonacolins from red yeast riceJ Agric Food Chem201260493493922224625
   PubMed Web of Science ®Google Scholar
• GordonRYBeckerDJThe role of red yeast rice for the physicianCurr Atheroscler Rep2011131738021061097
   PubMed Web of Science ®Google Scholar
• PrasadGVWongTMelitonGBhalooSRhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipientTransplantation20027481200120112438974
   PubMed Web of Science ®Google Scholar
• HalbertSCFrenchBGordonRYTolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intoleranceAm J Cardiol2010105219820420102918
   PubMed Web of Science ®Google Scholar
• KunclRWAgents and mechanisms of toxic myopathyCurr Opin Neurol200922550651519680127
   PubMed Web of Science ®Google Scholar
• KlimekMWangSOgunkanmiASafety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemiaP T200934631332719572049
   PubMedGoogle Scholar
• LinYLWangTHLeeMHSuNWBiologically active components and nutraceuticals in the Monascus-fermented rice: a reviewAppl Microbiol Biotechnol200877596597318038131
   PubMed Web of Science ®Google Scholar
• FlajsDPeraicaMToxicological properties of citrininArh Hig Rada Toksikol200960445746420061247
   PubMed Web of Science ®Google Scholar